Skip To Main Content
Donovan Jones on Muck Rack

Donovan Jones

San Francisco
As seen in: Seeking Alpha, Medium, MSN, Nurse Education in Practice, Frontiers, MDPI, Flipboard, Trading View, The Street, Morningstar, Journal of Nursing Education and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Donovan

Contact Donovan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Lyntris Seeks IPO On Growing Backlog For Integrated Battlefield Sensing

|
By Donovan Jones
| Seeking Alpha
Jul 29, 2026, 11:03 AM ET Summary Lyntris Inc. is pursuing an IPO to fund growth, leveraging an aggressive acquisition strategy for integrated sensing and connectivity solutions in defense markets. LYNX’s backlog surged to $924 million by mid-2026, but high debt service and reliance on government contracts create execution and concentration risks.
Open in Who Shared Issue with article?

Latigo Biotherapeutics Commences IPO Process For Pain Treatment Pipeline

|
By Donovan Jones
| Seeking Alpha
Summary Latigo Biotherapeutics is advancing a pipeline of non-opioid pain treatments, with lead candidate LTG-001 showing promising Phase 2 efficacy and no dependency signals. LTGO is targeting a large, growing non-opioid pain market projected to exceed $70 billion by 2030, driven by aging demographics and R&D investment.
Open in Who Shared Issue with article?

YPF Energia Electrica Targets U.S. IPO On Industry Opportunities In Argentina

|
By Donovan Jones
| Seeking Alpha
Jul 27, 2026, 12:03 PM ET Summary YPF Energia Electrica S.A. is a leading Argentine power generator seeking U.S. IPO funding amid sector deregulation and industry transition. YLUZ boasts revenue growth, robust EBITDA margins, and manageable leverage but faces gross margin compression and significant revenue concentration with CAMMESA. The IPO will not provide proceeds to YLUZ, limiting immediate growth capital, but a U.S. listing may facilitate future fundraising opportunities.
Open in Who Shared Issue with article?
See all 5,507 articles